MPC-11 Syngeneic Model

Synonyms: MPC11, MPC-11 plasmacytoma cell line

MPC-11 is a well-established cancer cell line derived from a murine plasmacytoma. It is commonly used in cancer research, particularly in the study of plasma cell malignancies. MPC-11 cells exhibit characteristics resembling plasma cells and serve as a valuable tool for investigating plasma cell biology, tumor progression, and therapeutic interventions. Researchers utilize MPC-11 to explore genetic alterations, signaling pathways, immune responses, and drug sensitivity in plasmacytoma research. The cell line is frequently employed in preclinical models to evaluate the efficacy of different treatment approaches, including chemotherapy, immunotherapy, and targeted therapies. The MPC-11 cell line plays a significant role in enhancing our understanding of plasma cell malignancies and developing novel strategies for diagnosis and treatment.

Model Details

Cancer Type: Hematopoietic Cancer
Model Name: MPC-11
Mouse Strain: balb/c
Treatment Data Available: N/A

MPC-11 Growth Curve

Growth of subcutaneous MPC-11 in balb/c mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content